Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Durect Corp (DRRX)

Durect Corp (DRRX)
0.5000 x 2 0.7380 x 2
Pre-market by (Cboe BZX)
0.7313 -0.0069 (-0.93%) 04/22/25 [NASDAQ]
0.5000 x 2 0.7380 x 2
Pre-market 0.7313 unch (unch) 16:00 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.7004
Day High
0.7350
Open 0.7004
Previous Close 0.7382 0.7382
Volume 15,600 15,600
Avg Vol 48,250 48,250
Stochastic %K 32.00% 32.00%
Weighted Alpha -47.36 -47.36
5-Day Change +0.0033 (+0.45%) +0.0033 (+0.45%)
52-Week Range 0.7000 - 1.8800 0.7000 - 1.8800
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,701
  • Shares Outstanding, K 31,042
  • Annual Sales, $ 2,030 K
  • Annual Income, $ -8,320 K
  • EBIT $ -19 M
  • EBITDA $ -19 M
  • 60-Month Beta 0.88
  • Price/Sales 11.28
  • Price/Cash Flow N/A
  • Price/Book 2.54
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.78
  • Most Recent Earnings $-0.06 on 03/26/25
  • Next Earnings Date 05/12/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Options Overview Details

View History
  • Implied Volatility 147.02% ( -127.59%)
  • Historical Volatility 55.45%
  • IV Percentile 60%
  • IV Rank 14.70%
  • IV High 941.25% on 11/15/24
  • IV Low 10.16% on 08/23/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 696
  • Open Int (30-Day) 1,349

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.14
  • Number of Estimates 2
  • High Estimate -0.13
  • Low Estimate -0.14
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +44.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7000 +4.47%
on 04/21/25
Period Open: 0.8490
0.8490 -13.86%
on 03/25/25
-0.1177 (-13.86%)
since 03/21/25
3-Month
0.7000 +4.47%
on 04/21/25
Period Open: 0.8411
0.8700 -15.94%
on 01/27/25
-0.1098 (-13.05%)
since 01/22/25
52-Week
0.7000 +4.47%
on 04/21/25
Period Open: 0.8050
1.8800 -61.10%
on 06/03/24
-0.0737 (-9.16%)
since 04/22/24

Most Recent Stories

More News
Durect: Q4 Earnings Snapshot

Durect: Q4 Earnings Snapshot

DRRX : 0.7313 (-0.93%)
Durect: Q3 Earnings Snapshot

Durect: Q3 Earnings Snapshot

DRRX : 0.7313 (-0.93%)
Durect: Q2 Earnings Snapshot

Durect: Q2 Earnings Snapshot

DRRX : 0.7313 (-0.93%)
Durect: Q1 Earnings Snapshot

Durect: Q1 Earnings Snapshot

DRRX : 0.7313 (-0.93%)
Durect: Q4 Earnings Snapshot

Durect: Q4 Earnings Snapshot

DRRX : 0.7313 (-0.93%)
Durect: Q3 Earnings Snapshot

Durect: Q3 Earnings Snapshot

DRRX : 0.7313 (-0.93%)
DURECT Corporation Announces Presentations in Upcoming Investor Conferences

/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver...

DRRX : 0.7313 (-0.93%)
Durect: Q2 Earnings Snapshot

Durect: Q2 Earnings Snapshot

DRRX : 0.7313 (-0.93%)
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update

/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended June 30, 2023 and provided a corporate update....

DRRX : 0.7313 (-0.93%)
DURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business Update

/PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver...

DRRX : 0.7313 (-0.93%)

Business Summary

Durect Corp. is pioneering the treatment of chronic diseases and conditions by developing and commercializing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time. Its pharmaceutical systems combine engineering innovations and delivery technology from...

See More

Key Turning Points

3rd Resistance Point 0.7787
2nd Resistance Point 0.7568
1st Resistance Point 0.7441
Last Price 0.7313
1st Support Level 0.7095
2nd Support Level 0.6876
3rd Support Level 0.6749

See More

52-Week High 1.8800
Fibonacci 61.8% 1.4292
Fibonacci 50% 1.2900
Fibonacci 38.2% 1.1508
Last Price 0.7313
52-Week Low 0.7000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro